Exchange Traded Concepts, LLC Compass Therapeutics, Inc. Transaction History
Exchange Traded Concepts, LLC
- $3.81 Billion
- Q1 2024
A detailed history of Exchange Traded Concepts, LLC transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 146,874 shares of CMPX stock, worth $120,436. This represents 0.01% of its overall portfolio holdings.
Number of Shares
146,874
Previous 65,819
123.15%
Holding current value
$120,436
Previous $102,000
184.31%
% of portfolio
0.01%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CMPX
# of Institutions
80Shares Held
94.2MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA22.4MShares$18.3 Million1.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.1MShares$9.13 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X06.49MShares$5.32 Million0.01% of portfolio
-
Blackstone Inc New York, NY6.19MShares$5.08 Million0.05% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$4.95 Million0.0% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $83.1M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...